ARCHIVES

Gleevec Better Than Interferon For Newly Diagnosed CML

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

New Saccharin Studies Convince FDA It A Carcinogen

July 15, 1977

NCI-Approved Clinical Trials

September 28, 2001

NCI Clarifies P01 Grant Application Dates

September 13, 1996

Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal.

June 27, 2003

Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent

January 8, 1982

Youth Smoking Linked To Exposure In Movies

December 30, 2005